Publicaciones en las que colabora con DANIEL SABATER HERNÁNDEZ (30)

2021

  1. Estudio de prevalencia de uso de la terapia Triple Whammy en farmacia comunitaria

    Ars pharmaceutica, Vol. 62, Núm. 1, pp. 40-40

2020

  1. Collaborative health service planning: A stakeholder analysis with social network analysis to develop a community pharmacy service

    Research in Social and Administrative Pharmacy, Vol. 16, Núm. 2, pp. 216-229

  2. Stakeholder analysis in health innovation planning processes: A systematic scoping review

    Health Policy, Vol. 124, Núm. 10, pp. 1083-1099

2017

  1. Cost analysis and cost-benefit analysis of a medication review with follow-up service in aged polypharmacy patients

    European Journal of Health Economics, Vol. 18, Núm. 9, pp. 1069-1078

  2. Cost analysis for the implementation of a medication review with follow-up service in Spain

    International Journal of Clinical Pharmacy, Vol. 39, Núm. 4, pp. 750-758

  3. Modelling elderly patients’ perception of the community pharmacist image when providing professional services*

    Psychology, Health and Medicine, Vol. 22, Núm. 5, pp. 578-587

  4. Patients' expectations of the role of the community pharmacist: Development and testing of a conceptual model

    Research in Social and Administrative Pharmacy, Vol. 13, Núm. 2, pp. 313-320

2016

  1. Healthcare professional-patient relationships: Systematic review of theoretical models from a community pharmacy perspective

    Patient Education and Counseling, Vol. 99, Núm. 3, pp. 339-347

  2. Intervention mapping for developing pharmacy-based services and health programs: A theoretical approach

    American Journal of Health-System Pharmacy

2015

  1. Assessment of a screening protocol for type 2 diabetes in community pharmacy. The DiabNow Study

    Diabetes Research and Clinical Practice, Vol. 108, Núm. 3, pp. e49-e52

  2. Cost-Utility Analysis of a Medication Review with Follow-Up Service for Older Adults with Polypharmacy in Community Pharmacies in Spain: The conSIGUE Program

    PharmacoEconomics, Vol. 33, Núm. 6, pp. 599-610

  3. Identifying masked uncontrolled hypertension in the community pharmacy setting

    Blood Pressure Monitoring, Vol. 20, Núm. 3, pp. 138-143

  4. Validity of home blood pressure measurements manually registered by patients after an educational session provided by community pharmacists

    Blood Pressure Monitoring, Vol. 20, Núm. 4, pp. 232-236

2014

  1. Lifestyles habits and sleep quality in patients over the age of 65 attending community pharmacies

    Latin American Journal of Pharmacy, Vol. 33, Núm. 5, pp. 739-745

2013

  1. Effect of a pharmacist intervention on asthma control. A cluster randomised trial

    Respiratory Medicine, Vol. 107, Núm. 9, pp. 1346-1355

  2. Get Impact Program. Evaluation clinical impact, economic and humanistic Pharmacotherapy follow adults greater polypharmacy

    Vitae

  3. Impact of a community pharmacists' hypertension-care service on medication adherence. The AFenPA study

    Research in Social and Administrative Pharmacy, Vol. 9, Núm. 6, pp. 797-805

  4. Investigación y conocimiento en Atención Farmacéutica: un binomio inseparable

    Ars pharmaceutica, Vol. 54, Núm. 2, pp. 1-3

  5. Relationship between urinary albumin excretion and blood pressure in the community pharmacy: The palmera study

    American Journal of Hypertension

2012

  1. Agreement between community pharmacy, physician's office, and home blood pressure measurement Methods : the palmera study

    American Journal of Hypertension, Vol. 25, Núm. 3, pp. 290-296